Al di là del fiume - attraverso il fiume: il basso corso del Ter in Catalogna

La ricerca prende in considerazione dal punto di vista dell’architettura e dell’urbanistica la relazione tra la città e il fiume che la attraversa o la lambisce; l’insediamento umano viene analizzato nel contesto del bacino idrografico al quale appartiene. La ricerca è stata sviluppata in seno alla tesi dottorale ora in fase di elaborazione presso il Departamento de Urbanismo y Ordenación del Territorio dell’Universidad Politecnica de Catalunya. La tesi ha come caso studio il tratto basso del fiume Ter in Catalogna. Nella discussione sul paesaggio urbano contemporaneo oggi la riflessione è centrata sulla città che si territorializza; la dimensione urbana interferisce con gran parte della superficie della terra facendo sfumare le tradizionali distinzioni tra urbano e non-urbano, tra spazio costruito e spazio aperto. In questo contesto, quale termine di conciliazione tra la dinamica naturale e la costruzione storica dei luoghi prodotta dall’intervento umano, il fiume si rivela uno strumento essenziale di analisi e progetto. L’obiettivo di questa ricerca è suggerire un’approssimazione al progetto della città che si sviluppa lungo il corso fluviale costruendo strumenti per la riflessione “attraverso il fiume”. Partendo dall’ipotesi che la città si insedia lungo un corso d’acqua secondo una sintassi territoriale stabilita dalla geografía e dalla geomorfologia del fiume stesso, il fine è fornire strumenti per il processo di recupero degli spazi fluviali in contesti urbanizzati. Il fiume diviene componente geografica chiave degli insediamenti dispersi e risorsa per costruirne l’abitabilità.

Al lado con la persona afectada por la enfermedad de Alzheimer en Huelva : instrumentos de mejora de la atención

Documento relacionado: Al lado, itinerario de atención compartida : Demencias, Alzheimer (http://hdl.handle.net/10668/487). Publicado en la página web de la Consejería de Salud y Bienestar Social: Consejería de Salud y Bienestar Social / Profesionales / Salud Pública / 'Al Lado' con... / 'Al Lado' con las personas afectadas por Alzheimer.

Could radiotherapy effectiveness be enhanced by electromagnetic field treatment?

One of the main goals in radiobiology research is to enhance radiotherapy effectiveness without provoking any increase in toxicity. In this context, it has been proposed that electromagnetic fields (EMFs), known to be modulators of proliferation rate, enhancers of apoptosis and inductors of genotoxicity, might control tumor recruitment and, thus, provide therapeutic benefits. Scientific evidence shows that the effects of ionizing radiation on cellular compartments and functions are strengthened by EMF. Although little is known about the potential role of EMFs in radiotherapy (RT), the radiosensitizing effect of EMFs described in the literature could support their use to improve radiation effectiveness. Thus, we hypothesized that EMF exposure might enhance the ionizing radiation effect on tumor cells, improving the effects of RT. The aim of this paper is to review reports of the effects of EMFs in biological systems and their potential therapeutic benefits in radiotherapy.

Long-term effectiveness of first-line antiretroviral theraphy in a cohort of HIV-1 infected patients.

Eligibility criteria might explain differences in viral response to combined antiretroviral treatment (cART) between clinical trials and routine care setting. Prospective analysis including HIV-1 infected patients starting cART between January 2004 and December 2009, at Hospital Universitari Vall d’Hebron. Effectiveness evaluated as time to treatment failure (TF), defined as virologic failure, loss to follow-up, death or treatment discontinuation whatever the reason other than switching. Effectiveness month 12, 24 and 36 was 82.9%, 78.5% and 76%, respectively. 57 (24.6%) patients presented TF, mainly due to intolerance or toxicity. Higher risk in patients starting before 2006 and those with protease inhibitor based regimen.

Impacto económico de los cruceros : del impacto Europeo al impacto local en Barcelona

En aquest treball volem analitzar i projectar l’impacte econòmic que suposa el turisme de creuers a Europa en general i la ciutat de Barcelona en particular, que compta amb el primer port de creuers més important d’Europa i el quart port base del món. En primer lloc repassarem breument el paper del turisme en el desenvolupament d’Espanya i més concretament de la ciutat comtal, des dels plans de desenvolupament iniciats en la dècada dels 60 fins a l’actualitat. A continuació donarem una ullada general al mercat dels creuers. Per tal d’entendre l’impacte del sector sobre el port de Barcelona haurem d’entendre prèviament l’evolució dels creuers en el mercat europeu, especialment a la regió Mediterrànea, ja que els vaixells que realitzen aquestes rutes son els que surten o fan escala a Barcelona. Un cop vists els dos conceptes bàsics dels quals tractarem, passarem a analitzar l’impacte econòmic procedent del turisme de creuers a nivell agregat d’ Europa i en concret de Barcelona. Per acabar farem un anàlisi de riscs i oportunitats per al sector.

Anàlisi cronològica de la pesca al Port de Llançà: període 1977-1996

A partir del buidatge exhaustiu dels fulls de subhasta del peix i de les fitxes tècniques de les embarcacions de la Confraria del Port de Llançà, es fa una anàlisi cronològica qualitativa i quantitativa dels darrers vint anys de pesca. La flota, inicialment constituïda per barques d'arrossegament i de pesca artesanal (palangre petit i tresmail), ha anat evolucionant, i ha quedat bàsicament constituïda actualment pel ròssec i el palangre de fons, que ha substituit progressivament la pesca artesanal. Les pesqueries, notablement multiespecífiques els primers anys, van donar pas, bàsicament amb la incorporació del radar, a una pesca molt més selectiva, dominada essencialment per la captura de lluç entre els anys 1980 i 1985. La progressiva incorporació del palangre de fons fa que a partir del 1986 es tendeixi novament cap a una captura més multiespecífica, perd amb canvis qualitatius importants en la composició d'espècies capturades en relació amb els primers anys

La vida al medi marí de la costa gironina

La vida al medi marí de la Costa Brava

Iconografia paleocristiana en ceràmiques estampades gàl·liques (d.s.p.) trobades al Nord-Est de Catalunya

Aquest article presenta un estudi detallat de peces ceràmiques que pertanyen al tipus ceràmic conegut com derivada de la sigil·lata paleocristiana (D.S.P.), obrada al migdia de la Gàl·lia des de molt a final del segle IV fins ben entrat el VI i exportada per tota la costa de la Mediterrània occidental

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study.

INTRODUCTION Tolerability and convenience are crucial aspects for the long-term success of combined antiretroviral therapy (cART). The aim of this study was to investigate the impact in routine clinical practice of switching to the single tablet regimen (STR) RPV/FTC/TDF in patients with intolerance to previous cART, in terms of patients' well-being, assessed by several validated measures. METHODS Prospective, multicenter study. Adult HIV-infected patients with viral load under 1.000 copies/mL while receiving a stable ART for at least the last three months and switched to RPV/FTC/TDF due to intolerance of previous regimen, were included. Analyses were performed by ITT. Presence/magnitude of symptoms (ACTG-HIV Symptom Index), quality of life (EQ-5D, EUROQoL & MOS-HIV), adherence (SMAQ), preference of treatment and perceived ease of medication (ESTAR) through 48 weeks were performed. RESULTS Interim analysis of 125 patients with 16 weeks of follow up was performed. 100 (80%) were male, mean age 46 years. Mean CD4 at baseline was 629.5±307.29 and 123 (98.4%) had viral load <50 copies/mL; 15% were HCV co-infected. Ninety two (73.6%) patients switched from a NNRTI (84.8% from EFV/FTC/TDF) and 33 (26.4%) from a PI/r. The most frequent reasons for switching were psychiatric disorders (51.2%), CNS adverse events (40.8%), gastrointestinal (19.2%) and metabolic disorders (19.2%). At the time of this analysis (week 16), four patients (3.2%) discontinued treatment: one due to adverse events, two virologic failures and one with no data. A total of 104 patients (83.2%) were virologically suppressed (<50 copies/mL). The average degree of discomfort in the ACTG-HIV Symptom Index significantly decreased from baseline (21±15.55) to week 4 (10.89±12.36) & week 16 (10.81±12.62), p<0.001. In all the patients, quality of life tools showed a significant benefit in well-being of the patients (Table 1). Adherence to therapy significantly and progressively increased (SMAQ) from baseline (54.4%) to week 4 (68%), p<0.001 and to week 16 (72.0%), p<0.001. CONCLUSIONS Switching to RPV/FTC/TDF from another ARV regimen due to toxicity, significantly improved the quality of life of HIV-infected patients, both in mental and physical components, and improved adherence to therapy while maintaining a good immune and virological response.

Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish society of internal medicine.

BACKGROUND Despite the progressive increase in life expectancy and the relationship between aging with multi-morbidities and the increased use of healthcare resources, current clinical practice guidelines (CPG) on cardiometabolic risk cannot be adequately applied to elderly subjects with multiple chronic conditions. Its management frequently becomes complicated by both, an excessive use of medications that may lead to overtreatment, drug interactions and increased toxicity, and errors in dosage and non-compliance. Concerned by this gap, the Spanish Society of Internal Medicine created a group of independent experts on cardiometabolic risk who discussed what they considered to be unanswered questions in the management of elderly patients. DISCUSSION Current guidelines do not specifically address the problem of elderly with multiple chronic conditions. For this reason, the combined use of the limited available evidence, clinical experience and common sense, could all help us to address this unmet need. In very old people, life expectancy and functionality are the most important factors for guiding potential treatments. Their higher propensity to develop serious adverse events and their shorter lifespan could prevent them from obtaining the potential benefits of the interventions administered. SUMMARY In this document, experts on cardiometabolic risk factors have established a number of consensual recommendations that have taken into account international guidelines and clinical experience, and have also considered the more effective use of healthcare resources. This document is intended to provide general recommendations for clinicians and to promote the effective use of procedures and medications.

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study.

BACKGROUND: Phase-IV, open-label, single-arm study (NCT01203917) to assess efficacy and safety/tolerability of first-line gefitinib in Caucasian patients with stage IIIA/B/IV, epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC). METHODS: TREATMENT: gefitinib 250 mg day(-1) until progression. Primary endpoint: objective response rate (ORR). Secondary endpoints: disease control rate (DCR), progression-free survival (PFS), overall survival (OS) and safety/tolerability. Pre-planned exploratory objective: EGFR mutation analysis in matched tumour and plasma samples. RESULTS: Of 1060 screened patients with NSCLC (859 known mutation status; 118 positive, mutation frequency 14%), 106 with EGFR sensitising mutations were enrolled (female 70.8%; adenocarcinoma 97.2%; never-smoker 64.2%). At data cutoff: ORR 69.8% (95% confidence interval (CI) 60.5-77.7), DCR 90.6% (95% CI 83.5-94.8), median PFS 9.7 months (95% CI 8.5-11.0), median OS 19.2 months (95% CI 17.0-NC; 27% maturity). Most common adverse events (AEs; any grade): rash (44.9%), diarrhoea (30.8%); CTC (Common Toxicity Criteria) grade 3/4 AEs: 15%; SAEs: 19%. Baseline plasma 1 samples were available in 803 patients (784 known mutation status; 82 positive; mutation frequency 10%). Plasma 1 EGFR mutation test sensitivity: 65.7% (95% CI 55.8-74.7). CONCLUSION: First-line gefitinib was effective and well tolerated in Caucasian patients with EGFR mutation-positive NSCLC. Plasma samples could be considered for mutation analysis if tumour tissue is unavailable.

Itinerari d’EA des de Tamariu fins al far de Sant Sebastià

Creació d’un itinerari d’educació ambiental des de Tamariu fins al far de Sant Sebastià, al municipi de Palafrugell, per tal de sensibilitzar i conscienciar la societat sobre la necessitat de conservar el medi.S’ha fet una diagnosi per tal d’estudiar les mancances i necessitats que sorgeixen al llarg del camí. A partir d’aquesta anàlisi s’ha elaborat una sèrie de propostes divulgatives i didàctiques per tal d’adequar l’itinerari com a eina d’educació ambiental

Implantació d’un ecobarri al Pla d’en Serra, Sant Gregori

La finalitat del projecte consisteix en establir les pautes per a la implantació d’un model d’ecobarri al Pla d’en Serra, un barri situat a l’est del municipi de Sant Gregori, el qual, com a conseqüència de la crisi, es troba urbanitzat i pendent d’edificació. Per tal d’assolir l’objectiu proposat es fa èmfasi en aspectes d’usos del sòl, mobilitat, metabolisme i governança. Inclou un estudi previ amb la diagnosi de l’estat actual de la zona i dels Plans influents, enquesta a la població, diagnosi de conflictes i potencialitats entre el model d’ecobarri i el model tradicional.El model que resulta de l’elaboració d’aquest projecte és el d’un barri més sostenible, més respectuós amb el medi ambient, proporciona una major comoditat i qualitat de vida per als futurs habitants de la comunitat en comparació a les perspectives que se li donen actualment a la zona